Biomarin Pharmaceutical Inc
XBER:BM8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biomarin Pharmaceutical Inc
XBER:BM8
|
US |
|
F
|
Fastenal Co
F:FAS
|
US |
|
C
|
Compagnie Financiere Richemont SA
OTC:CFRUY
|
CH |
|
E
|
Eaton Corporation PLC
XMUN:3EC
|
IE |
|
C
|
CF Industries Holdings Inc
DUS:C4F
|
US |
|
T
|
Toronto-Dominion Bank
XMUN:TDB
|
CA |
|
V
|
Vodafone Group PLC
OTC:VODPF
|
UK |
|
I
|
Interpublic Group of Companies Inc
F:IPG
|
US |
|
W
|
Westwing Group SE
XBER:WEW
|
DE |
|
L
|
Lipocine Inc
F:2VT
|
US |
|
Getinge AB
LSE:0GZV
|
SE |
|
Ke Holdings Inc
F:KE8A
|
CN |
Wall St Price Targets
BM8 Price Targets Summary
Biomarin Pharmaceutical Inc
According to Wall Street analysts, the average 1-year price target for BM8 is 80.37 EUR with a low forecast of 44.64 EUR and a high forecast of 111.38 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BM8's stock price target?
Price Target
80.37
EUR
According to Wall Street analysts, the average 1-year price target for BM8 is 80.37 EUR with a low forecast of 44.64 EUR and a high forecast of 111.38 EUR.
What is the Revenue forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 3 years is 15%.
What is the Gross Profit forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 3 years is 15%.
What is the Operating Income forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
28%
The compound annual growth rate for Operating Income over the next 3 years is 28%.
What is the Pre-Tax Income forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
53%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 53%.
What is the Net Income forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
60%
The compound annual growth rate for Net Income over the next 3 years is 60%.
